RXD vs. XTJL
RXD (ProShares UltraShort Health Care) and XTJL (Innovator U.S. Equity Accelerated Plus ETF - July) are both Leveraged Equities funds. RXD is passively managed, while XTJL is actively managed. Over the past 5 years, RXD returned -8.36%/yr vs 9.83%/yr for XTJL. At a correlation of -0.57, they often move in opposite directions. RXD charges 0.95%/yr vs 0.79%/yr for XTJL.
Performance
RXD vs. XTJL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RXD achieves a -9.19% return, which is significantly lower than XTJL's 5.97% return.
RXD
- 1D
- -4.64%
- 1M
- -12.05%
- 6M
- -7.00%
- YTD
- -9.19%
- 1Y
- -31.61%
- 3Y*
- -10.78%
- 5Y*
- -8.36%
- 10Y*
- -19.81%
XTJL
- 1D
- -0.42%
- 1M
- 0.38%
- 6M
- 5.24%
- YTD
- 5.97%
- 1Y
- 13.86%
- 3Y*
- 14.08%
- 5Y*
- 9.83%
- 10Y*
- —
RXD vs. XTJL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
RXD ProShares UltraShort Health Care | -9.19% | -21.66% | 4.83% | 3.25% | 1.20% | -20.03% |
XTJL Innovator U.S. Equity Accelerated Plus ETF - July | 5.97% | 15.42% | 14.43% | 25.72% | -15.66% | 7.81% |
Correlation
The correlation between RXD and XTJL is -0.25, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.25 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.43 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.57 |
Correlation (All Time) Calculated using the full available price history since Jul 1, 2021 | -0.57 |
Over the past year, the inverse relationship between RXD and XTJL has weakened: their correlation has moved from -0.57 to -0.25, meaning they move in opposite directions less often than they have historically.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RXD vs. XTJL — Risk / Return Rank
RXD
XTJL
RXD vs. XTJL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Health Care (RXD) and Innovator U.S. Equity Accelerated Plus ETF - July (XTJL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RXD | XTJL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.89 | ||
| Sortino ratioReturn per unit of downside risk | -4.13 | ||
| Omega ratioGain probability vs. loss probability | 0.84 | 1.41 | -0.57 |
| Calmar ratioReturn relative to maximum drawdown | -0.82 | 2.72 | -3.54 |
| Martin ratioReturn relative to average drawdown | -1.29 | 15.38 | -16.67 |
Loading charts...
Drawdowns
RXD vs. XTJL - Drawdown Comparison
The maximum RXD drawdown since its inception was -99.67%, which is greater than XTJL's maximum drawdown of -23.24%. Use the drawdown chart below to compare losses from any high point for RXD and XTJL.
Loading charts...
Drawdown Indicators
| RXD | XTJL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.67% | -23.24% | -76.43% |
Max Drawdown (1Y)Largest decline over 1 year | -38.77% | -5.12% | -33.65% |
Max Drawdown (3Y)Largest decline over 3 years | -40.62% | -16.70% | -23.92% |
Max Drawdown (5Y)Largest decline over 5 years | -44.27% | -23.24% | -21.03% |
Max Drawdown (10Y)Largest decline over 10 years | -91.23% | — | — |
Current DrawdownCurrent decline from peak | -99.66% | -0.42% | -99.24% |
Average DrawdownAverage peak-to-trough decline | -81.96% | -3.95% | -78.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.61% | 0.90% | +23.71% |
Volatility
RXD vs. XTJL - Volatility Comparison
ProShares UltraShort Health Care (RXD) has a higher volatility of 12.04% compared to Innovator U.S. Equity Accelerated Plus ETF - July (XTJL) at 1.39%. This indicates that RXD's price experiences larger fluctuations and is considered to be riskier than XTJL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RXD | XTJL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.04% | 1.39% | +10.65% |
Volatility (6M)Calculated over the trailing 6-month period | 23.68% | 5.73% | +17.95% |
Volatility (1Y)Calculated over the trailing 1-year period | 31.49% | 7.40% | +24.09% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 30.25% | 15.10% | +15.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.07% | 15.05% | +18.02% |
RXD vs. XTJL - Expense Ratio Comparison
RXD has a 0.95% expense ratio, which is higher than XTJL's 0.79% expense ratio.
Dividends
RXD vs. XTJL - Dividend Comparison
RXD's dividend yield for the trailing twelve months is around 3.27%, while XTJL has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
RXD ProShares UltraShort Health Care | 3.27% | 3.29% | 4.36% | 3.17% | 0.67% | 0.00% | 0.17% | 1.73% | 0.22% |
XTJL Innovator U.S. Equity Accelerated Plus ETF - July | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
RXD and XTJL have a correlation of -0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RXD has higher volatility (12.04%) compared to XTJL (1.39%). In terms of maximum drawdown, RXD dropped -99.67% vs XTJL's -23.24%.
On 5-year performance, XTJL leads with 9.83% vs -8.36% for RXD. On fees, XTJL is cheaper at 0.79% per year. On volatility, XTJL has been the lower-risk option at 1.39%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, XTJL has performed better with a 9.83% return vs -8.36%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XTJL is cheaper with a 0.79% expense ratio, compared with 0.95% for RXD.
RXD has the higher dividend yield at 3.27%, compared with 0.00% for XTJL.
They also come from different issuers: ProShares and Innovator. Their fees differ too: 0.95% for RXD and 0.79% for XTJL.
XTJL currently has the higher Sharpe Ratio (1.88 vs -1.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RXD and XTJL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer